Humanity's best friend

Dogs' highly evolved noses can rapidly detect the SARS-CoV-2 virus

Newswise — For some 15,000 years, dogs have been our hunting partners, workmates, helpers and companions. Could they also be our next allies in the fight against COVID-19?

According to UC Santa Barbara professor emeritus Tommy Dickey(link is external) and his collaborator, BioScent researcher Heather Junqueira, they can. And with a review paper(link is external) published in the Journal of Osteopathic Medicine they have added to a small but growing consensus that trained medical scent dogs can effectively be used for screening individuals who may be infected with the COVID-19 virus.

This follows a comprehensive survey of research devoted to the use of trained scent dogs for detecting COVID. "The most striking result is that studies have already demonstrated that dogs can identify people who are COVID-19 positive," Dickey said of their findings. "Not only that," he added, "they can do it non-intrusively, more rapidly and with comparable or possibly better accuracy than our conventional detection tests."

Not surprisingly, the magic lies in canine sense of smell, which gives dogs the ability to detect molecules in tiny concentrations -- "one part in a quadrillion compared with one part in one billion for humans," according to the paper. Add to that other optimizations for smell, such as a large nasal area and the structure of their noses, which allows inflow through the nostrils and outflow through nasal folds. Further, with 125-300 million olfactory cells and a third of their brains devoted to interpreting odors, dogs are well equipped with the ability to sniff out the volatile organic compounds that indicate the presence of COVID.

"The dogs are basically smelling the sweat of the person," Dickey said of a series of experiments by French and Lebanese researchers(link is external) testing canines' capacity to sense COVID infection. Although the virus itself has no odor, metabolic products excreted by COVID-positive individuals through their sweat glands were detected by the 18 dogs selected for the study (16 Belgian malinois, one German shepherd and one Jack Russell terrier) with an accuracy rate of 83-100% after only four days of training. True failures, according to the study, could be attributed to "distractive external smells or movements by a TV filming crew."

"One dog twice indicated positive results that could not be confirmed," Dickey said. "Two weeks later they found that both people who gave those samples had to be hospitalized with COVID."

Meanwhile, a German research group employed eight scent detection dogs(link is external) in a randomized, double-blind controlled pilot study. The group trained the dogs for a week and then set them to sniffing 1,012 samples of saliva or tracheobronchial secretions. They returned an average detection rate of 94% with a sensitivity (ability to detect a true positive) of 67.9% to 95.2% and a specificity (ability to detect a true negative) of 92.4% to 98.9%. This pilot study used positive samples from severely affected individuals and negative samples from people with no symptoms. Future studies, according to that paper, could focus more on identifying different phases of infection or perhaps the detection of different disease phenotypes.

Using dogs to detect disease is not new. In fact, co-author Junqueira has previously published results showing that her scent dogs (beagles, bassett hounds and mixes of the two) can effectively detect non-small cell lung cancer.

"Canines are capable of detecting other types of cancer as well as malaria, Parkinson's disease and diabetes," Junqueira said, adding that "medical scent dog research has really only gained traction in recent years and that it will take many more peer-reviewed papers before the idea of using dogs for disease detection hits the mainstream."

Dickey's own interest in the subject was sparked over the course of his work as a therapy dog handler of three Great Pyrenees (over 3,000 therapy dog visits), a longtime avocation he leaned on after cancer forced him to retire from UC Santa Barbara's Department of Geography in 2013. "I loved UCSB," he said. "I loved teaching and I brought my therapy dogs to class all the time. I just had the life, what can I say?"

In fact, he couldn't stay away -- he and his dogs have been on hand to see the UCSB community through hard times, offering their shaggy coats, wet noses and calm demeanors through tragedy and stress. In retirement, Dickey has published three therapy dog books for children, some of which recount stories of their UCSB therapy dog adventures. In addition, he and his canines have presented educational demonstrations at the California Science Center and the Los Angeles Public Library, work that sparked his interest in the power of a dog's sense of smell for medical detection.

So when the new disease called COVID-19 hit, Dickey was primed to ask: Can dogs detect the novel coronavirus? Naturally, there was little in the way of refereed research on the topic, so he teamed up with Junqueira, who was already conducting her own COVID detection research(link is external) with her scent dogs in Florida. "One of our big motivations was to write a peer-reviewed paper that basically gave a progress report," he said. "Where are we? Is this stuff really possible?"

Dickey and Junqueira found that researchers used a variety of dogs. "There were a lot of Belgian malinois that were used, and dogs who have been trained on explosives and on colon cancer. So they were pro sniffers," Junqueira said. "Other groups, such as the one behind a Colombian study(link is external), were motivated by the need to find a quick, accurate and cost-effective form of COVID early detection." The Colombian group utilized a variety of dogs -- four Belgian malinois, one Alaskan malamute-Siberian mix and an American pit bull terrier.

"The pit bull had been previously mistreated," Dickey said, "but they rehabilitated him, and he was perfectly capable and doing a great job at sniffing." After almost two months of training and thousands of samples later, this Colombian canine cohort performed with a remarkable 95.5% sensitivity and 99.6% specificity.

During the various blind, controlled experiments, the total time for detection was a matter of minutes or less. Such speed is a huge asset in real world scenarios. In particular, a U.K.-based research group(link is external) has outlined their plans to train and ultimately deploy dogs at United Kingdom airports and ports of entry as part of the COVID-19 screening process.

With all the sniffing going on in the presence of an airborne disease, it's natural to be concerned over whether dogs can catch and transmit COVID-19. It's still the topic of ongoing research, but evidence points to a low likelihood of transmission, according to the paper, though precautionary measures should be taken to protect everyone involved.

"Current research supports the use of scent detection dogs for pilot COVID-19 screening studies involving humans in venues such as airports and sporting events," Dickey said. "In addition, the JOM paper points out that another line of research can utilize medical scent detection dogs involving the development of medical electronic noses."

In principle, you wouldn't even need a dog to sniff out COVID if you could mimic the way it smells and processes scents, according to the researchers. Through sensors and artificial intelligence, they said, it might be possible to someday match a dog's performance using wearable electronic noses, similar to wristband sensors for reporting heart beat rate and patterns, blood pressure and oxygen, that could monitor a person's sweat for metabolites and biomarkers that could indicate diseases such as COVID-19.



Filters close

Showing results

110 of 5419
Released: 15-Apr-2021 4:10 PM EDT
Penn Study Suggests Those Who Had COVID-19 May Only Need One Vaccine Dose
Perelman School of Medicine at the University of Pennsylvania

New findings from Penn suggest that people who have recovered from COVID-19 may only need a single mRNA vaccine dose. However, those who did not have COVID-19 did not have a full immune response until after a second vaccine dose, reinforcing the importance of completing the two recommended doses.

Released: 15-Apr-2021 4:00 PM EDT
June 2021 Issue of AJPH Comprises the Effects of COVID-19 on Drug Overdoses, E-cigarette Use, and Public Health Measures and Strategies
American Public Health Association (APHA)

June 2021 AJPH Issue highlights COVID-19 concerns in relation to fatal drug overdoses, drops in youth e-cigarette use, importance of public health measures, and strategies to protect correctional staff.

Newswise: 262150_web.jpg
Released: 15-Apr-2021 3:20 PM EDT
COVID-19 reduces access to opioid dependency treatment for new patients
Princeton University

COVID-19 has been associated with increases in opioid overdose deaths, which may be in part because the pandemic limited access to buprenorphine, a treatment used for opioid dependency, according to a new study led by Princeton University researchers.

Newswise: UGA to Establish National NIH-funded Center to Fight Flu
Released: 15-Apr-2021 2:45 PM EDT
UGA to Establish National NIH-funded Center to Fight Flu
University of Georgia

The National Institutes of Health has awarded the University of Georgia a contract to establish the Center for Influenza Disease and Emergence Research (CIDER). The contract will provide $1 million in first-year funding and is expected to be supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of NIH, for seven years and up to approximately $92 million.

Released: 15-Apr-2021 2:15 PM EDT
Meatpacking plants increased COVID-19 cases in US counties
University of California, Davis

An estimated 334,000 COVID-19 cases are attributable to meatpacking plants, resulting in $11.2 billion in economic damage, according to a new study led by a researcher at the University of California, Davis.

Newswise: 262052_web.jpg
Released: 15-Apr-2021 1:55 PM EDT
How to build a city that prioritizes public health
Colorado State University

Most people by now have memorized the public health guidelines meant to help minimize transmission of COVID-19: wash your hands, wear a mask, keep six feet apart from others. That part is easy.

Released: 15-Apr-2021 1:45 PM EDT
Wake Forest School of Medicine Begins Study to Test New Mask for Healthcare Workers
Wake Forest Baptist Health

Open Standard Industries, Inc. (OSI), manufacturer of the OSR-M1 non-valved reusable elastomeric face mask, is pleased to formally announce the launch of its first Institutional Review Board (IRB)-approved user feasibility study. The trial is being led by the departments of Biomedical Engineering and Infectious Diseases at Wake Forest School of Medicine, part of Wake Forest Baptist Health. Recruitment in the study is underway, and enrollment is expected to be completed by May 28, 2021.

Newswise: Major clinical trial to test Pfizer-BioNTech COVID-19 vaccine opens for enrollment at UTHealth in Houston
Released: 15-Apr-2021 1:45 PM EDT
Major clinical trial to test Pfizer-BioNTech COVID-19 vaccine opens for enrollment at UTHealth in Houston
University of Texas Health Science Center at Houston

A large national clinical trial to evaluate the Pfizer-BioNTech COVID-19 vaccine for safety and efficacy in pregnant women is now open for enrollment at The University of Texas Health Science Center at Houston (UTHealth).

Released: 15-Apr-2021 1:15 PM EDT
For veterans, a hidden side effect of COVID: Feelings of personal growth
Yale University

The U.S. military veteran population is known to have abnormally high rates of suicide, so health officials have been concerned that the COVID-19 pandemic might elevate risk of psychiatric disorders, particularly among those suffering from post-traumatic stress and related disorders.

Newswise: 262026_web.jpg
Released: 15-Apr-2021 12:55 PM EDT
Significant spread of all coronavirus variants tracked in Houston area

In late 2020, several concerning SARS-CoV-2 variants emerged globally. They are believed to be more easily transmissible, and there is concern that some may reduce the effectiveness of antibody treatments and vaccines.

Showing results

110 of 5419